Company Filing History:
1 out of 13 
1 out of 6 Years Active: 2006
Title: Christoph Reichel: A Pioneer in Hybrid Assay Systems
Introduction
Christoph Reichel is a notable inventor based in Planegg, Germany, recognized for his innovative contributions to the field of hybrid assay systems. With one patent to his name, he has made significant strides in the isolation of ligand binding polypeptides and small molecule ligands, showcasing his expertise and dedication to advancement in scientific research.
Latest Patents
Reichel's patent, titled "Three Hybrid Assay System," presents compositions and methods designed for isolating ligand binding polypeptides in relation to user-specified ligands. Additionally, it involves isolating small molecule ligands tailored for a user-specified target polypeptide using an improved class of hybrid ligand compounds. This invention addresses crucial needs in biochemical research, enabling more targeted and efficient methodologies.
Career Highlights
Throughout his career, Christoph Reichel has worked with esteemed organizations, notably with GPC Biotech, Inc. and GPC Biotech AG. His experiences in these companies have contributed to his robust understanding of the biotechnology landscape, paving the way for his patent and future innovations.
Collaborations
In his journey of innovation, Reichel has collaborated with talented individuals, including coworkers Jon H. Come and Frank Becker. These partnerships have likely enriched his research endeavors, fostering an environment of shared knowledge and expertise within the field.
Conclusion
In summary, Christoph Reichel stands out as a distinguished inventor in the realm of hybrid assay systems. His patent demonstrates his commitment to enhancing methodologies in biological research. With his background and collaborative spirit, Reichel's contributions are certain to inspire further advancements in the industry.